1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Teduglutide 1.2.3 Linaclotide 1.2.4 Others 1.3 Market by Application 1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2017-2028) 2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Region 2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics 2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Trends 2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers 2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges 2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue 3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue 3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio 3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2021 3.5 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served 3.6 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service 3.7 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type 4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2023-2028) 5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application 5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028) 6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) 6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028) 7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) 7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028) 9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) 9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Takeda 11.1.1 Takeda Company Detail 11.1.2 Takeda Business Overview 11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction 11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) 11.1.5 Takeda Recent Development 11.2 Ironwood Pharmaceuticals 11.2.1 Ironwood Pharmaceuticals Company Detail 11.2.2 Ironwood Pharmaceuticals Business Overview 11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction 11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) 11.2.5 Ironwood Pharmaceuticals Recent Development 11.3 Astellas Pharma 11.3.1 Astellas Pharma Company Detail 11.3.2 Astellas Pharma Business Overview 11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction 11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) 11.3.5 Astellas Pharma Recent Development 11.4 Allergan 11.4.1 Allergan Company Detail 11.4.2 Allergan Business Overview 11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction 11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) 11.4.5 Allergan Recent Development 11.5 Takeda Pharmaceutical 11.5.1 Takeda Pharmaceutical Company Detail 11.5.2 Takeda Pharmaceutical Business Overview 11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction 11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) 11.5.5 Takeda Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Teduglutide Table 3. Key Players of Linaclotide Table 4. Key Players of Others Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2017-2022) Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2023-2028) Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2017-2022) Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2021) Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service Table 22. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2017-2022) Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2023-2028) Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2017-2022) Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2023-2028) Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 42. Takeda Company Detail Table 43. Takeda Business Overview Table 44. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product Table 45. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million) Table 46. Takeda Recent Development Table 47. Ironwood Pharmaceuticals Company Detail Table 48. Ironwood Pharmaceuticals Business Overview Table 49. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product Table 50. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million) Table 51. Ironwood Pharmaceuticals Recent Development Table 52. Astellas Pharma Company Detail Table 53. Astellas Pharma Business Overview Table 54. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product Table 55. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million) Table 56. Astellas Pharma Recent Development Table 57. Allergan Company Detail Table 58. Allergan Business Overview Table 59. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product Table 60. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million) Table 61. Allergan Recent Development Table 62. Takeda Pharmaceutical Company Detail Table 63. Takeda Pharmaceutical Business Overview Table 64. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product Table 65. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million) Table 66. Takeda Pharmaceutical Recent Development Table 67. Research Programs/Design for This Report Table 68. Key Data Information from Secondary Sources Table 69. Key Data Information from Primary Sources List of Figures Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Teduglutide Features Figure 3. Linaclotide Features Figure 4. Others Features Figure 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application in 2021 & 2028 Figure 6. Hospital Pharmacies Case Studies Figure 7. Retail Pharmacies Case Studies Figure 8. Online Pharmacies Case Studies Figure 9. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered Figure 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region: 2021 VS 2028 Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2021 Figure 14. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2021 Figure 16. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2017-2028) Figure 18. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2017-2028) Figure 22. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2017-2028) Figure 30. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2017-2028) Figure 38. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2017-2028) Figure 42. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) Figure 45. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) Figure 46. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) Figure 47. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Takeda Ironwood Pharmaceuticals Astellas Pharma Allergan Takeda Pharmaceutical